The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramakrishna, C.
Right arrow Articles by Bergmann, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramakrishna, C.
Right arrow Articles by Bergmann, C. C.
The Journal of Immunology, 2004, 173: 6265-6273.
Copyright © 2004 by The American Association of Immunologists

Differential Regulation of Primary and Secondary CD8+ T Cells in the Central Nervous System1

Chandran Ramakrishna*, Stephen A. Stohlman*,{dagger}, Roscoe A. Atkinson{dagger}, David R. Hinton{dagger} and Cornelia C. Bergmann2,*,{dagger}

Departments of * Neurology and {dagger} Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033

T cell accumulation and effector function following CNS infection is limited by a paucity of Ag presentation and inhibitory factors characteristic of the CNS environment. Differential susceptibilities of primary and recall CD8+ T cell responses to the inhibitory CNS environment were monitored in naive and CD8+ T cell-immune mice challenged with a neurotropic coronavirus. Accelerated virus clearance and limited spread in immunized mice was associated with a rapid and increased CNS influx of virus-specific secondary CD8+ T cells. CNS-derived secondary CD8+ T cells exhibited increased cytolytic activity and IFN-{gamma} expression per cell compared with primary CD8+ T cells. However, both Ag-specific primary and secondary CD8+ T cells demonstrated similar contraction rates. Thus, CNS persistence of increased numbers of secondary CD8+ T cells reflected differences in the initial pool size during peak inflammation rather than enhanced survival. Unlike primary CD8+ T cells, persisting secondary CD8+ T cells retained ex vivo cytolytic activity and expressed high levels of IFN-{gamma} following Ag stimulation. However, both primary and secondary CD8+ T cells exhibited reduced capacity to produce TNF-{alpha}, differentiating them from effector memory T cells. Activation of primary and secondary CD8+ T cells in the same host using adoptive transfers confirmed similar survival, but enhanced and prolonged effector function of secondary CD8+ T cells in the CNS. These data suggest that an instructional program intrinsic to T cell differentiation, rather than Ag load or factors in the inflamed CNS, prominently regulate CD8+ T cell function.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. M. Gonzalez, C. C. Bergmann, C. Ramakrishna, D. R. Hinton, R. Atkinson, J. Hoskin, W. B. Macklin, and S. A. Stohlman
Inhibition of Interferon-{gamma} Signaling in Oligodendroglia Delays Coronavirus Clearance without Altering Demyelination
Am. J. Pathol., March 1, 2006; 168(3): 796 - 804.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Ramakrishna, R. A. Atkinson, S. A. Stohlman, and C. C. Bergmann
Vaccine-Induced Memory CD8+ T Cells Cannot Prevent Central Nervous System Virus Reactivation.
J. Immunol., March 1, 2006; 176(5): 3062 - 3069.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. A. Friese and L. Fugger
Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Brain, August 1, 2005; 128(8): 1747 - 1763.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.